<DOC>
	<DOC>NCT02154464</DOC>
	<brief_summary>The investigators predict that giving patients paracetamol in the operative period will reduce their need for opioid pain reducers in the post operative setting.</brief_summary>
	<brief_title>Morphine-sparing Effect of Intravenous Paracetamol for Post-operative Pain Management Following Laparoscopic Gastric Banding in Morbidly Obese Patients</brief_title>
	<detailed_description>This study is designed as a population-based prospective, double blind cohort study. A prospective cohort of patients admitted to laparoscopic gastric banding due to morbid obesity STUDY GOALS - To evaluate the morphine-sparing effect of paracetamol IV in obese patients undergoing bariatric surgery. - To identify potential ability of paracetamol IV to attenuate or relief postoperative pain in obesity patient undergoing bariatric surgery - To determine effectiveness of paracetamol IV to reduce postoperative complication rate.</detailed_description>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Age â‰¥18 years Patients admitted for laparoscopic gastric banding Elective surgery BMI &gt; 40 ASA (American Society Anesthesiologists perioperative risk stratification) class 12 Patients' refusal to participate in the study Patients unable to give an informed consent Pregnancy Emergent surgery Patient with known allergy to morphine or paracetamol Patient with hepatic failure (based on history or elevated liver enzymes). ASA class &gt;2.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Morphine-sparing</keyword>
	<keyword>Paracetamol</keyword>
	<keyword>Obesity</keyword>
	<keyword>Gastric banding</keyword>
</DOC>